GlaxoSmithKline wins $1.25 billion HIV patent dispute
Pharmaceutical giant GlaxoSmithKline (GSK) said its specialist HIV unit ViiV Healthcare had settled a global patent infringement case it brought against US rival Gilead Sciences in 2018.ViiV healthcare which is owned by...
02 February 2022
